SLC6A3 and Parkinson disease: The study of Rahmim et al. (30) combined with radiomic analysis in the routine measurement of DAT SPECT significantly improved the diagnosis of Parkinson's outcome and believed that radiomics were expected to become an effective biomarker for Parkinson's diagnosis.